Myeloprotection With Trilaciclib in Pan-cancer Population

Clinical trial NCT06297811 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06297811
Sponsor: Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Breast Cancer Endometrial Cancer Cervical Cancer Head And Neck Squamous Cell Carcinomas

Start date: 2024-03-01
Primary completion: 2025-09-30
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.